Literature DB >> 26987461

Pneumococcal Conjugate Vaccine--Equally Effective for Everyone?

Tobias Welte1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26987461      PMCID： PMC4802350          DOI： 10.3238/arztebl.2016.0137

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  10 in total

Review 1.  Clinical and economic burden of community-acquired pneumonia among adults in Europe.

Authors:  T Welte; A Torres; D Nathwani
Journal:  Thorax       Date:  2010-08-20       Impact factor: 9.139

2.  New antibiotic development: the need versus the costs.

Authors:  Tobias Welte
Journal:  Lancet Infect Dis       Date:  2016-02-05       Impact factor: 25.071

3.  Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study.

Authors:  Santiago Ewig; Benjamin Klapdor; Mathias W Pletz; Gernot Rohde; Hartwig Schütte; Tom Schaberg; Torsten T Bauer; Tobias Welte
Journal:  Thorax       Date:  2011-11-05       Impact factor: 9.139

4.  23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial.

Authors:  N French; J Nakiyingi; L M Carpenter; E Lugada; C Watera; K Moi; M Moore; D Antvelink; D Mulder; E N Janoff; J Whitworth; C F Gilks
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

Review 5.  The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Hannah Ewald; Matthias Briel; Danielle Vuichard; Veronika Kreutle; Andriy Zhydkov; Viktoria Gloy
Journal:  Dtsch Arztebl Int       Date:  2016-03-04       Impact factor: 5.594

6.  The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ.

Authors:  M W Pletz; H von Baum; M van der Linden; G Rohde; H Schütte; N Suttorp; T Welte
Journal:  Pneumologie       Date:  2012-08-08

7.  Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort.

Authors:  Dean T Eurich; Thomas J Marrie; Jasjeet K Minhas-Sandhu; Sumit R Majumdar
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 8.  Vaccines for preventing pneumococcal infection in adults.

Authors:  Sarah Moberley; John Holden; David Paul Tatham; Ross M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

9.  Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.

Authors:  Simon Rückinger; Mark van der Linden; Ralf René Reinert; Rüdiger von Kries; Florian Burckhardt; Anette Siedler
Journal:  Vaccine       Date:  2009-05-09       Impact factor: 3.641

10.  Efficacy of pneumococcal vaccination in adults: a meta-analysis.

Authors:  Anke Huss; Pippa Scott; Andreas E Stuck; Caroline Trotter; Matthias Egger
Journal:  CMAJ       Date:  2009-01-06       Impact factor: 8.262
  10 in total
  2 in total

1.  Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen.

Authors:  A-Yeung Jang; Ho Seong Seo; Shunmei Lin; Gook-Hyun Chung; Han Wool Kim; Sangyong Lim; Lei Zhao; In Ho Park; Jae Hyang Lim; Kyung-Hyo Kim
Journal:  Virulence       Date:  2017-01-06       Impact factor: 5.882

Review 2.  Mind the "Vaccine Fatigue".

Authors:  Zhaohui Su; Ali Cheshmehzangi; Dean McDonnell; Claudimar Pereira da Veiga; Yu-Tao Xiang
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.